Vera Therapeutics Inc (VERA) (Q3 2026) Earnings Call Highlights: TRUTAKNA Launch Off to a ...
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics Q3 Earnings Call Highlights
Vera Therapeutics (VERA) Stock Looks Above Fair Value After A 148% Run
Vera Therapeutics, Inc. Q3 2026 Earnings Call Summary
Wedbush Maintains Neutral on Vera Therapeutics, Lowers Price Target to $29
Guggenheim Maintains Buy on Vera Therapeutics, Lowers Price Target to $66
HC Wainwright & Co. Maintains Buy on Vera Therapeutics, Lowers Price Target to $75
Vera Therapeutics (VERA) Q3 2026 Earnings Call Transcript
Vera Therapeutics, Inc. (VERA) Reports Q3 Loss, Tops Revenue Estimates
Vera Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results
Vera Therapeutics, Inc. (VERA) Q3 2026 Earnings Call Transcript
Vera Therapeutics Q3 EPS $(1.30) Beats $(1.62) Estimate, Sales $10.277M Beat $3.398M Estimate
Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
Vera Therapeutics' TRUTAKNA Delivers Strong Phase III IgA Nephropathy Results
Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of Medicine
Vera Therapeutics Announces Its ORIGIN 3 Study Of TRUTAKNA In Adults With Primary IgA Nephropathy Achieves Primary Endpoint Of Proteinuria Reduction At 36 Weeks
Vera Therapeutics to Host ASN Kidney Week Investor Webcast and Third Quarter 2026 Financial Results Conference Webcast
Leerink Partners Initiates Coverage On Vera Therapeutics with Market Perform Rating, Announces Price Target of $34
Do Vera Therapeutics' (VERA) High-Profile IgAN Data Show Durable Moat or Crowded Mechanism Risk?
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.